Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Horm, Srey Viseth ^a   Mardy, Sek ^a,b   Rith, Sareth ^a   Ly, Sovann ^c   Heng, Seng ^c   Vong, Sirenda ^a   Kitsutani, Paul ^d   Ieng, Vannra ^b   Tarantola, Arnaud ^a   Ly, Sowath ^a   Sar, Borann ^e   Chea, Nora ^e   Sokhal, Buth ^f   Barr, Ian ^g   Kelso, Anne ^g   Horwood, Paul F ^a   Timmermans, Ans ^h   Hurt, Aeron ^g   Lon, Chanthap ^h   Saunders, David ^h   Ung, Sam An ^f   Asgari, Nima ^b   Roces, Maria Concepcion ^b   Touch, Sok ^c   Komadina, Naomi ^g   Buchy, Philippe ^a   more..

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Ministry of Health Cambodia   (Cambodia)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f National Institute of Public Health   (Cambodia)

^g WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^h ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CAMBODIA; CHILD; FEMALE; FLU LIKE SYNDROME; GENE SEQUENCE; HUMAN; INFANT; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; LOWER RESPIRATORY TRACT INFECTION; M2 GENE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHYLOGENY; VERY ELDERLY; VIROLOGY; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; DOG; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MDCK CELL LINE; ORTHOMYXOVIRIDAE; PHYSIOLOGY; SEASON;

ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGENS, VIRAL; CAMBODIA; DOGS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; ORTHOMYXOVIRIDAE; PHYLOGENY; SEASONS;

EID: 84908538097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110713     Document Type: Article

References (58)

1. Simonsen L, Clarke MJ, Williamson G.D., Stroup DF, Arden HA, et al. (1997) The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 87: 1944-1950.
2. Thompson WW, Shay DK, Weintraub E, Brammer L., Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
3. Dawood FS, Luliano AD, Reed C, Meltzer M.I., Shay DK, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modeling study. Lancet Infect Dis 12: 687-695.
4. Finkelman BS, Viboud C, Koelle K., Ferrari MJ, Bharti N, et al. (2007) Global Patterns in Seasonal Activity of Influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral Coexistence and Latitudinal Gradients. PLos One 12: e1296.
5. Shek LP, Lee BW (2003) Epidemiology and seasonality of respiratory tract infections in the tropics. Paediatr Respir Rev 4: 104-111.
6. Beckett CG, Hosasih H, Ma'roef C, Listiyonengsih E, Elyazar IRF, et al. (2004) Influenza surveillance in Indonesia: 1999-2003. Clin Infect Dis 39: 443-449.
7. Doraisingham S, Goh KT, Ling A.E., Yu M (1988) Influenza surveillance in Singapore: 1972-86. Bull World Health Organ 66: 57-63.
8. Nguyen HLK, Saito R, Ngiem H.K., Nishikawa M., Shobugawa Y, et al. (2007) Epidemiology of influenza in Hanoi, Vietnam, from 2001 to 2003. J Infect 55: 58-63.
9. Rao BL, Banerjee K (1993) Influenza surveillance in Pune, India. Bull World Health Organ, 71: 177-181.
10. Tsai HP, Kuo PH, Liu C.C., Wang JR et al. (2001) Respiratory viral infections among inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 39: 111-118.
11. Members of the Western Pacific Region Global Influenza Surveillance and Response System (2012) Epidemiological and Virological Characteristics of Influenza in the Western Pacific Region of the World Health Organization, 2006-2010. PLoS ONE 7: e37568.
12. Mardy S, Ly S, Heng S., Vong S, Huch C, et al. (2009) Influenza activity in Cambodia during 2006-2008. BMC Infect Dis 9: 168.
13. Viboud C, Alonso WJ, Simonsen L (2006) Influenza in tropical regions. PLoS Med 3: 0468-0471.
14. Webster RG, Bean WJ, Gorman O.T., Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
15. National Institute of Statistics, Phnom Penh, Cambodia. Final census results (2nd ed.) (2002) General population census of Cambodia 1998.
16. World Health Organization (2008) A guide to establishing event-based surveillance. Available: http://www.wpro.who.int/internet/resources.ashx/CSR/Publications/eventbasedsurv.pdf. Accessed 21 March 2011.
17. World Health Organization (2009) CDC protocol of realtime RT-PCR for influenza A (H1N1). Available: http://www.who.int/csr/resources/publications/swineflu/realtimertpcr/en/index/html. Accessed 21 March 2011.
18. World Health Organization (2007) Recommendations for laboratory procedures to detect avian influenza A H5N1 virus in specimens from suspected human cases. Available: http://www.who.int/csr/disease/avian-influenza/guidelines/RecAIlabtestsAug07.pdf Accessed 21 March 2011.
19. Larkin MA, Blackshields G, Brown N.P., Chenna R., McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23: 2947-2948.
20. ∗: Phylogenetic Analysis Using Parsimony (and other methods) 4.0 Beta. Available: paup.csit.fsu.edu/about.html. Accessed 21 March 2011.
21. Naughtin M, Dyason JC, Mardy S, Sorn S., von Itzstein M, et al. (2011) Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 virus. Antimicrob Agents Chemother 55: 2004-2010.
22. Blair PJ, Wierzba TF, Touch S, Vonthanak S., Xu X, et al. (2010) Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. Epidemiol Infect 138: 199-209.
23. Nair H, Brooks WA, Katz M, Roca A., Berkley JA, et al. (2011) Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378: 1917-1930.
24. O'Brien KL, Walters MI, Sellman J (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30: 784-789.
25. McCullers JA, McAuley JL, Browall S, Iverson A.R., Boyd KL, et al. (2010) Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 202: 1287-1295.
26. World Health Organization (2009) Human infection with pandemic A(H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 84: 301-308.
27. Hope-Simpson RE (1981) The role of season in the epidemiology of influenza. J Hyg 86: 35-47.
28. Chittaganpitch M, Supawat K, Olsen S.J., Waicharoen S., Patthamadilok S, et al. (2012) Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004-2010. Influenza Other Respir Viruses 6: 276-283.
29. Jian JW, Chen JW, Lai C.T., Hsu LC, Chen PJ, et al. (2008) Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clinic Microbiol 46: 1426-1434.
30. World Health Organization (2011) Influenza A(H1N1) 2009 virus: current situation and post-pandemic recommendations. Wkly Epidemiol Rec 86: 61-72.
31. World Health Organization (2010) Recommended viruses of influenza vaccines for use in the 2011 influenza season (Southern hemisphere). Wkly Epidemiol Rec 85: 61-72.
32. World Health Organization (2010) Global Influenza Program, Influenza update. Available: http://www.who.int/csr/disease/influenza/2010-12-30-GIP-surveillance/en/index.html Accessed 22 March 2011.
33. Members of the Western Pacific Region Global Influenza Surveillance and Response System (2013) Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. WPSAR 4: doi:10.5365.
34. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis T.R., et al. (2005) Incidence of amantadine resistance among influenza A(H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concerne. Lancet 366: 1175-1181.
35. Bright R, Shay D, Shu B., Cox N, Klimov A (2006) Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295: 891-894.
36. Barr I, Deng Y, Iannello P., Hurt A, Komadina N (2008) Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antivir. Res 80: 200-205.
37. Leang SK, Deng YM, Shaw R, Caldwell N., Iannello P, et al. (2013) Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Res 97: 206-210.
38. He G, Qiao J, Dong C., He C, Zhao L, et al. (2008) Amantadine resistance among H5N1 avian influenza viruses isolated in Northern China. Antivir Res 77: 72-76.
39. Simonsen L, Viboud C, Grenfell B.T., Dushoff J., Jennings L, et al. (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24: 1811-1820.
40. Ilyushina N, Govorkova E, Webster R (2005) Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology 341: 102-106.
41. McKimm-Breschkin JL, Trivedi T, Hampson A., Hay A, Klimov A, et al. (2003) Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother 47: 2264-2272.
42. Hurt AC, Barr IG (2008) Influenza viruses with reduced sensitivity to the NA inhibitor drugs in untreated young children. Commun Dis Intell 32: 57-62.
43. Fourment M, Mardy S, Channa M., Buchy P (2010) Evidence for persistence of and antiviral resistance and reassortment events in seasonal influenza virus strains circulating in Cambodia. J Clin Microbiol 48: 295-297.
44. Hurt AC, Ernest J, Deng Y.M., Iannello P., Besselaar TG, et al. (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antivir Res 83: 90-93.
45. Monto AS, McKimm-Breschkin JL, Macken C., Hampson AW, Hay A, et al. (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50: 2395-2402.
46. Holmes EC, Ghedin E, Miller N., Taylor J, Bao Y, et al. (2005) Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 3: 1579-1588.
47. Pariani E, Fratt ER, Amendola A, Zappa A., Bianchi S, et al. (2009) Molecular characterization and phlylogenetic analysis of human influenza A viruses in three consecutive seasons with different epidemiological profiles. J Prev Med Hyg 50: 113-116.
48. Nelson MI, Simonsen L, Viboud C., Miller MA, Holmes EC (2007) Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLos Pathogens 3: 1220-1228.
49. Nelson M, Spiro D, Wentworth D., Fan J, Beck E, et al. (2009) The early diversification of influenza A/H1N1pdm. PLoS Curr 1: RRN1126.
50. Potdar VA, Chadha MS, Jadhav S.M., Mullick J., Cherian SS, et al. (2010) Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS ONE 3: e9693.
51. Stevens J, Corper AL, Basler C.F., Taubenberger JK, Palese P, et al. (2004) Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303: 1866-1870.
52. Glinsky GV (2010) Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 9: 958-970.
53. Igarashi M, Ito K, Yoshida R., Tomabechi D, Kida H, et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 1: e8553.
54. Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L., Phuah SP, et al. (2010) A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2: RRN1162
55. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
56. McCullers JA, Wang GC, He S, Webster RG (1999) Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 73: 7343-7348.
57. Tsai HP, Wang HC, Kiang D, Huang S.W., Kuo PH, et al. (2006) Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol 44: 2705-2713.
58. CDC (2011) Influenza Antiviral Medications: A Summary for Clinicians. Available: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.